Search Results for 'focal therapeutics'
-
-
Diagnostics | Surgical
Past Dues: Medtech's 2018 Year in Review
The industry confronted old ghosts in 2018 as it defended itself against a documentary and crammed for regulatory changes.Michael Barbella, Managing Editor 11.26.18
-
Surgical
Hologic to Acquire Focal Therapeutics for $125M to Strengthen Breast Surgery Franchise
Focal's BioZorb is an implantable 3D marker that helps clinicians overcome challenges in breast-conserving surgery.Business Wire 09.27.18
-
The ISO 13485:2016 Transition Journey
Results of an ASQ Biomedical Division survey on the move to the new standard are shared.Jim Shore, Chair-Elect, ASQ Biomedical Division 06.04.18
-
R&D & Design
Focal Therapeutics Launches BioZorb LP
More than 200 U.S. centers now offer bioabsorbable marker used in breast conservation therapy.Business Wire 04.11.16
